NCT03624699View on ClinicalTrials.gov

Investigation of the iStent Inject® Devices in Open-Angle Glaucoma

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
Glaucoma, Open-Angle
Interventions
DEVICE

Glaukos iStent inject®

iStent inject® Devices Implanted in Combination with Cataract Surgery in Patients with Open-Angle Glaucoma

Trial Locations (1)

1006

Glaucoma Research Centre, Montchoisi Clinic, Lausanne

Sponsors

Collaborators (1)

Glaukos Corporation
All Listed Sponsors
collaborator

Glaukos Corporation

INDUSTRY

lead

Dr. Kaweh Mansouri

OTHER

NCT03624699 - Investigation of the iStent Inject® Devices in Open-Angle Glaucoma | Biotech Hunter | Biotech Hunter